These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7963780)

  • 1. The use of hypodermoclysis for rehydration in terminally ill cancer patients.
    Fainsinger RL; MacEachern T; Miller MJ; Bruera E; Spachynski K; Kuehn N; Hanson J
    J Pain Symptom Manage; 1994 Jul; 9(5):298-302. PubMed ID: 7963780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypodermoclysis (HDC) for symptom control vs. the Edmonton Injector (EI).
    Fainsinger RL; Bruera E
    J Palliat Care; 1991; 7(4):5-8. PubMed ID: 1783966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypodermoclysis to treat dehydration: a review of the evidence.
    Remington R; Hultman T
    J Am Geriatr Soc; 2007 Dec; 55(12):2051-5. PubMed ID: 17971137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions and decision-making on rehydration of terminally ill cancer patients and family members.
    Morita T; Tsunoda J; Inoue S; Chihara S
    Am J Hosp Palliat Care; 1999; 16(3):509-16. PubMed ID: 10661058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When to treat dehydration in a terminally ill patient?
    Fainsinger RL; Bruera E
    Support Care Cancer; 1997 May; 5(3):205-11. PubMed ID: 9176966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods of hydration in palliative care patients.
    Steiner N; Bruera E
    J Palliat Care; 1998; 14(2):6-13. PubMed ID: 9686490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proctoclysis for hydration of terminally ill cancer patients.
    Bruera E; Pruvost M; Schoeller T; Montejo G; Watanabe S
    J Pain Symptom Manage; 1998 Apr; 15(4):216-9. PubMed ID: 9601155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehydration in cancer patients: to treat or not to treat.
    Dalal S; Bruera E
    J Support Oncol; 2004; 2(6):467-79, 483. PubMed ID: 15605914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous hydration by hypodermoclysis. A practical and low cost treatment for elderly patients.
    Frisoli Junior A; de Paula AP; Feldman D; Nasri F
    Drugs Aging; 2000 Apr; 16(4):313-9. PubMed ID: 10874526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydration management at the end of life.
    Lanuke K; Fainsinger RL; DeMoissac D
    J Palliat Med; 2004 Apr; 7(2):257-63. PubMed ID: 15130203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypodermoclysis as a Strategy for Patients With End-of-Life Cancer in Home Care Settings.
    Coelho TA; Wainstein AJA; Drummond-Lage AP
    Am J Hosp Palliat Care; 2020 Sep; 37(9):675-682. PubMed ID: 31902225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial rehydration in the last days of life: is it beneficial?
    Bavin L
    Int J Palliat Nurs; 2007 Sep; 13(9):445-9. PubMed ID: 18026063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Subcutaneous perfusion of hypodermoclysis: a useful rehydration method in geriatrics].
    Dardaine V; Ferry M; Constans T
    Presse Med; 1999 Dec 18-25; 28(40):2246-50. PubMed ID: 10636020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and effectiveness of hypodermoclysis compared to intravenous fluid infusion for rehydrating children with mild to moderate dehydration: a systematic review protocol.
    Saganski GF; de Souza Freire MH
    JBI Database System Rev Implement Rep; 2019 Jul; 17(7):1270-1276. PubMed ID: 30889070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of the sensation of thirst in terminally ill cancer patients.
    Morita T; Tei Y; Tsunoda J; Inoue S; Chihara S
    Support Care Cancer; 2001 May; 9(3):177-86. PubMed ID: 11401102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypodermoclysis for rehydration in the community.
    Moriarty D; Hudson E
    Br J Community Nurs; 2001 Sep; 6(9):437-43. PubMed ID: 11832815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized clinical trial of recombinant human hyaluronidase-facilitated subcutaneous versus intravenous rehydration in mild to moderately dehydrated children in the emergency department.
    Spandorfer PR; Mace SE; Okada PJ; Simon HK; Allen CH; Spiro DM; Friend K; Harb G; Lebel F;
    Clin Ther; 2012 Nov; 34(11):2232-45. PubMed ID: 23062548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluid status of terminally ill cancer patients with intestinal obstruction: an exploratory observational study.
    Morita T; Tei Y; Inoue S; Suga A; Chihara S
    Support Care Cancer; 2002 Sep; 10(6):474-9. PubMed ID: 12353126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Biochemical dehydration and fluid retention symptoms in terminally ill cancer patients whose death is impending.
    Morita T; Ichiki T; Tsunoda J; Inoue S; Chihara S
    J Palliat Care; 1998; 14(4):60-1. PubMed ID: 9893401
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypodermoclysis for control of dehydration in terminal-stage cancer.
    Cerchietti L; Navigante A; Sauri A; Palazzo F
    Int J Palliat Nurs; 2000 Sep; 6(8):370-4. PubMed ID: 12411847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.